Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-17T19:12:02.481Z Has data issue: false hasContentIssue false
  • English
  • Français

Bias in the evaluation of antidepressants

Published online by Cambridge University Press:  11 October 2011

Matthew Hotopf  and
Corrado Barbui
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 14 , Issue 2 , June 2005 , pp. 55 - 57
Copyright
Copyright © Cambridge University Press 2005

References

REFERENCES

Anderson, I.M. (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders 58, 19–36.CrossRefGoogle ScholarPubMed
Anderson, I.M. (2001). Meta-analytical studies on new antidepressants. British Medical Bulletin 57, 161–178.CrossRefGoogle ScholarPubMed
Barbui, C. & Hotopf, M. (2001a). Amitriptyline versus the rest: still the leading antidepressant after 40 years of randomised controlled trials. British Journal of Psychiatry 178, 129–144.CrossRefGoogle Scholar
Barbui, C. & Hotopf, M. (2001b). 40 years of antidepressant drug trials. Acta Psychiatrica Scandinavica 104, 92–95.CrossRefGoogle ScholarPubMed
Barbui, C.Hotopf, M., Freemantle, N., Boyton, J., Churchill, R., Eccles, M.P., Geddes, J.R., Hardy, R., Lewis, G. & Mason, J.M. (2000). Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database of Systematic Reviews. Issue 4.CrossRefGoogle Scholar
Barbui, C.Hotopf, M. & Garattini, S. (2002). Fluoxetine dose and out-come in antidepressant drug trials. European Journal of Clinical Pharmacology 58, 379–386.CrossRefGoogle Scholar
Barbui, C, Percudani, M. & Hotopf, M. (2003). Economic evaluation of antidepressive agents: a systematic critique of experimental and observational studies. Journal of Clinical Psvchopharmacologv 23, 145–154.CrossRefGoogle ScholarPubMed
Barbui, C, Guaiana, G. & Hotopf, M. (2004a). Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysis. Phannacopsychiatry 37, 93–97.Google ScholarPubMed
Barbui, C, Cipriani, A., Brambilla, P. & Hotopf, M. (2004b). Wish bias in antidepressant drug trials? Journal of Clinical Psvchopharmacologv 24, 126–130.CrossRefGoogle ScholarPubMed
Ciuna, A., Andretta, M., Corbari, L., Levi, D., Mirandola, M., Sorio, A. & Barbui, C. (2004). Are we going to increase the use of antidepressants up to that of benzodiazepines? European Journal of Clinical Pharmacology 60(9), 629–634.CrossRefGoogle ScholarPubMed
Hotopf, M., Lewis, G. & Normand, C. (1996). Are SSRIs a cost-effective alternative to tricyclics? British Journal of Psychiatry 168, 404–409.CrossRefGoogle ScholarPubMed
Hotopf, M., Hardy, R. & Lewis, G. (1997a). Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry 170, 120–127.CrossRefGoogle ScholarPubMed
Hotopf, M., Lewis, G. & Normand, C. (1997b). Putting trials on trial: the costs and consequences of small clinical trials in depression: a systematic review of methodology Journal of Epidemiology and Community Health 51 354–358.CrossRefGoogle ScholarPubMed
Isacsson, G., Boethius, G. & Henriksson, S. (1999). Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. Journal of Affective Disorders 53, 15–22.CrossRefGoogle ScholarPubMed
Joffe, R., Sokolov, S. & Streiner, D. (1996). Antidepressant treatment of depression. A meta-analysis. Canadian Journal of Psychiatry 41, 613–616.CrossRefGoogle Scholar
Lawrenson, R.A., Tyrer, F. & Newson, R.B. (2000). The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. Journal of Affective Disorders 59, 149–157.CrossRefGoogle ScholarPubMed
Middlcton, N., Gunnell, D. & Whitley, E. (2001). Secular trends in antidepressant prescribing in the UK, 1975-1998. Journal of Public Health Medicine 23, 262–267.CrossRefGoogle Scholar
Parker, G., Anderson, I.M. & Haddad, P. (2003). Clinical trials of antidepressant medications are producing meaningless results. British Journal of Psychiatry 183, 102–104.CrossRefGoogle ScholarPubMed
Perry, P.J. (1996). Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of Affective Disorders 39, 1–6.CrossRefGoogle ScholarPubMed
Rosholm, J.U., Andersen, M. & Gram, L.F. (2001). Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. European Journal of Clinical Pharmacology 56, 923–929.CrossRefGoogle ScholarPubMed
Whittington, C.J., Kendall, f., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363, 1341–1345.CrossRefGoogle ScholarPubMed